Healthcare Investments and Exits
Deal counts fell from more than 1,300 at the peak in H1 2021 to just 618 in H1 2026, a new multiyear low reflecting concentration of capital in fewer companies.
Company · US · 2 documents
Deal counts fell from more than 1,300 at the peak in H1 2021 to just 618 in H1 2026, a new multiyear low reflecting concentration of capital in fewer companies.
AI companies make up 20% of all women's health deals and command triple the valuation of non-AI peers.